These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 542190)
1. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine. Joss RA; Goldberg RS; Yates JW Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190 [TBL] [Abstract][Full Text] [Related]
2. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460 [TBL] [Abstract][Full Text] [Related]
3. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea. Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu). Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492 [TBL] [Abstract][Full Text] [Related]
5. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep). Kemeny N; Yagoda A; Braun D Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study. White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275). Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814 [TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU. Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233 [TBL] [Abstract][Full Text] [Related]
9. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer. Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364 [TBL] [Abstract][Full Text] [Related]
10. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764). Shaw MT; Bonnet JD; Wilson H; Heilbrun LK Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758 [TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion. Kane RC; Cashdollar MR; Bernath AM Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554 [TBL] [Abstract][Full Text] [Related]
12. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep). Kemeny N; Yagoda A; Braun D; Golbey R Cancer; 1980 Mar; 45(5):876-81. PubMed ID: 7260839 [TBL] [Abstract][Full Text] [Related]
13. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma. Kemeny N; Yagoda A; Braun D; Golbey R Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group. J Clin Oncol; 1984 Jul; 2(7):770-3. PubMed ID: 6234380 [TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU. Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652 [No Abstract] [Full Text] [Related]
16. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492 [TBL] [Abstract][Full Text] [Related]
17. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer. Belt RJ; Stephens R Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer. Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974 [TBL] [Abstract][Full Text] [Related]